The α1 subunit of GABAA receptor is repressed by c-Myc and is pro-apoptotic

Journal of Cellular Biochemistry

Volumn 97, Issue 5, 2006, Pages 1094-1103

  Vaknin, Uri A ^a   Hann, Stephen R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; c Myc; GABAA receptor; Gene repression

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; MYC PROTEIN; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; RECEPTOR SUBTYPE; CASP3 PROTEIN, MOUSE; CASP3 PROTEIN, RAT; CASPASE; CASPASE 3; MESSENGER RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DEGENERATIVE DISEASE; GENE ACTIVATION; GENE REPRESSION; GENE TARGETING; NERVE CELL; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; NONHUMAN; NULL CELL; ONCOGENE C MYC; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR GENE; ANIMAL; CELL STRAIN 3T3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; RAT;

ANIMALIA; MAMMALIA;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; NIH 3T3 CELLS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RECEPTORS, GABA-A; RNA, MESSENGER; SUPPRESSION, GENETIC; TRANSCRIPTION, GENETIC;

EID: 33645239664     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20708     Document Type: Article

References (27)

1. Brooks-Kayal AR, Prichett DB. 1993. Developmental changes in human gamma-aminobutyric acidA receptor subunit composition. Ann Neurol 34:687-693.
2. Carlson BX, Elster L, Schousboe A. 1998. Pharmacological and functional implications of developmentally-regulated changes in GABA(A) receptor subunit expression in he cerebellum. Eur J Pharmacol 352:1-14.
3. Connolly C, Krishek B, McDonald B, Smart T, Moss S. 1996. Assembly and cell surface expression of heteromeric and homomeric gamma-aminobutyric acid type A receptors. J Biol Chem 271:89-96.
4. Eischen C, Packham G, Nip J, Fee B, Hiebert S, Zambetti G, Cleveland J. 2001. Bcl-2 is an apoptotic target suppressed by both c-myc and E2F-1. Oncogene 20: 6983-6993.
5. Fisher JL. 2004. A mutation in the GABAA receptor alpha 1 subunit linked to human epilepsy affects channel gating properties. Neuropharmacology 46:629-637.
6. Ganguly K, Schinder AF, Wong ST, Poo M. 2001. GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition. Cell 105:521-532.
7. Gregory MA, Qi Y, Hann SR. 2003. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 278:51606-51612.
8. Hanson KD, Shichiri M, Follansbee MR, Sedivy JM. 1994. Effects of c-myc expression on cell cycle progression. Mol Cell Bio 14:5748-5755.
9. Kuo TH, Kim HR, Zhu L, Yu Y, Lin HM, Tsang W. 1998. Modulation of endoplasmic reticulum calcium pump by Bcl-2. Oncogene 17:1903-1910.
10. Lambert N, Grover L. 1995. The mechanism of biphasic GABA responses. Science 269:977-981.
11. Luk KC, Sadikot AF. 2001. GABA promotes survival but not proliferation of parvalbumin-immunoreactive interneurons in rodent neostriatum: An in vivo study with stereology. Neuroscience 104:93-103.
12. Macdonald RL, Olsen RW. 1994. GABAA receptor channels. Annu Rev Neurosci 17:569-602.
13. Maric D, Liu QY, Maric I, Chaudry S, Chang YH, Smith SV, Sieghart W, Fritschy JM, Barker JL. 2001. GABA expression dominates neuronal lineage progression in the embryonic rat neocortex and facilitates neurite outgrowth via GABA(A) autoreceptor/Cl-channels. J Neurosci 21:2343-2360.
14. Mattson MP, LaFerla FM, Chan SL, Leissring MA, Shepel PN, Geiger JD. 2000. Calcium signaling in the ER: Its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 23:222-229.
15. McBurney MW, Reuhl KR, Ally AI, Nasipuri S, Bell JC, Craig J. 1998. Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. J Neurosci 8:1063-1073.
16. McKernan RM, Whiting PJ. 1996. Which GABAA-receptor subtypes really occur in the brain. Trends Neurosci 19: 139-143.
17. Nesbit CE, Tersak JM, Prochownik EV. 1999. MYC oncogenes and human neoplastic disease. Oncogene 18:3004-3016.
18. Oster SK, Ho CS, Soucie EL, Penn LZ. 2002. The myc oncogene: MarvelousIY complex. Adv Cancer Res 84: 81-154.
19. Paschen W. 2001. Dependence of vital cell function on endoplasmic reticulum calcium levels: Implications for the mechanisms underlying neuronal cell injury in different pathological states. Cell Calcium 29:1-11.
20. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45-e55.
21. Ruppert C, Goldowitz D, Wille W. 1986. Proto-oncogene c-myc is expressed in cerebellar neurons at different developmental stages. EMBO J 5:1897-1901.
22. St-Arnaud R, Nepveu A, Marcu KB, McBurney MW. 1988. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells. Oncogene 3:553-559.
23. Synowitz M, Ahmann P, Matyash M, Kuhn S, Hofmann B, Zimmer C, Kirchhohh F, Kiwit J, Kettermann H. 2001. GABA(A)-receptor expression in glioma cells is triggered by contact with neuronal cells. Eur J Neorosci 14:1294-1302.
24. Thompson EB. 1998. The many roles of c-myc in apoptosis. Annu Rev Physiol 60:575-600.
25. Whiting PJ, McKernan RM, Wafford KA. 1995. Structure and pharmacology of vertebrate GABAA receptor subtypes. Int Rev Neurobiol 38:95-138.
26. Xiao Q, Claassen G, Shi J, Adachi S, Sedivy J, Hann SR. 1998. Transactivation-defective c-mycS retains the ability to regulate proliferation and apoptosis. Genes Dev 12:3803-3808.
27. Zimmerman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D, Gee CE, et al. 1986. Differential expression of myc family genes during murine development. Nature 319:780-783.